Pulnovo Medical Emphasizes Pulmonary Hypertension Focus and PADN Platform

A LinkedIn post from Pulnovo Medical highlights the company’s participation in World Pulmonary Hypertension Day 2026 and aligns its mission with the event’s theme, “Hope in Every Trial.” The post emphasizes that clinical practice and therapeutic exploration in pulmonary hypertension are framed as incremental steps toward improving patients’ quality of life.

The company’s LinkedIn post underscores its focus on pulmonary hypertension through its PADN technology, which is portrayed as an original innovation and a “bridge of hope” linking scientific rigor with patient outcomes. The promotion of an upcoming PADN webinar suggests ongoing efforts in physician and stakeholder education, which could support long‑term adoption, reinforce Pulnovo’s positioning in the MedTech segment, and potentially enhance the commercial prospects of its pulmonary hypertension portfolio.